Insights

A&M Newsletters
Comprehensive and timely perspectives, on the topics that matter to you, sent straight to your inbox.
Created
Press Releases

Spanish Banking Pulse de la banca – Q2 2022: Industry benchmarks and top performers

October 6, 2022
The global professional services firm Alvarez & Marsal ("A&M") today announced the results of the sixteenth edition of "The Pulse of Spanish Banking". This study analyzes the evolution of the top ten Spanish banks in terms of growth, liquidity, efficiency, risk, profitability and solvency throughout the second quarter of 2022, highlighting the key performance indicators of the industry and scoring them according to the KPIs related to each area of analysis.  Additionally, the report analyzes the impact of moratoriums and public guarantee schemes (ICOs), the potential impact of cost pressures and inflation, and ESG criteria as a business opportunity.
Thought Leadership

Disclosure Pilot Scheme: Here to Stay

October 5, 2022
At Alvarez & Marsal we have been following the Disclosure Pilot Scheme (DPS) closely since its inception in 2018, whilst also helping our clients navigate their disclosure obligations in a world that is constantly evolving. 
Thought Leadership

6 Ways to Solve the Teacher Shortage in School Districts

September 30, 2022
Managing Director Erin Covington recently wrote an article that was featured in Education Week, where she discusses the ESSER funds in more detail and how they can help with the teacher shortage.
Thought Leadership

Employee Ownership Trusts (“EOTs”) as a succession option

September 30, 2022
2022 to date has been particularly challenging for public market investors. Central banks are increasingly determined to rein in inflation at a point where several factors (including the Ukraine conflict) have presented persistent pressures in this respect.
Thought Leadership

Evolving Investment Strategies in the Life Sciences

September 29, 2022
Arpita Singhal, Managing Director of Alvarez & Marsal’s Life Sciences division, gives EBR the inside scoop on investment trends within the biopharma industry today, addressing areas such as risk exposure, industry trends, and future growth potential.